WSFS
REGN icon

Wilmington Savings Fund Society’s Regeneron Pharmaceuticals REGN Stock Holding History

Wilmington Savings Fund Society’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.1K Hold
106
– – ﹤0.01% 837
2026
Q1 		$81.9K Hold
106
– – ﹤0.01% 782
2025
Q4 		$81.8K Hold
106
– – ﹤0.01% 783
2025
Q3 		$59.6K Sell
106
-620
-85% -$351K ﹤0.01% 857
2025
Q2 		$381K Sell
726
-505
-41% -$282K 0.01% 647
2025
Q1 		$781K Sell
1,231
-464
-27% -$319K 0.01% 465
2024
Q4 		$1.21M Sell
1,695
-115
-6% -$96.5K 0.02% 394
2024
Q3 		$1.9M Buy
1,810
+1,193
+193% +$1.33M 0.03% 322
2024
Q2 		$648K Sell
617
-10
-2% -$9.69K 0.02% 237
2024
Q1 		$603K Buy
+627
New +$596K 0.02% 245
2023
Q3 		$523K Sell
635
-26
-4% -$20.4K 0.02% 252
2023
Q2 		$475K Hold
661
– – 0.02% 269
2023
Q1 		$543K Buy
661
+9
+1% +$6.79K 0.02% 245
2022
Q4 		$470K Hold
652
– – 0.02% 256
2022
Q3 		$449K Hold
652
– – 0.02% 256
2022
Q2 		$385K Hold
652
– – 0.02% 278
2022
Q1 		$455K Hold
652
– – 0.02% 278
2021
Q4 		$412K Hold
652
– – 0.01% 298
2021
Q3 		$395K Hold
652
– – 0.02% 299
2021
Q2 		$364K Sell
652
-4
-0.6% -$2.03K 0.01% 313
2021
Q1 		$310K Sell
656
-407
-38% -$198K 0.01% 320
2020
Q4 		$514K Buy
+1,063
New +$574K 0.02% 274

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Wilmington Savings Fund Society's REGN Position: Q2 2026 in Review

Wilmington Savings Fund Society held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 106 shares worth $66.1K. The position accounts for ﹤0.01% of the portfolio, ranked #837.

Wilmington Savings Fund Society first reported a position in REGN in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.9M in Q3 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Wilmington Savings Fund Society held 106 shares of Regeneron Pharmaceuticals worth $66.1K as of Q2 2026.
  • Wilmington Savings Fund Society left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #837 holding.
  • Wilmington Savings Fund Society first reported a position in Regeneron Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
  • Wilmington Savings Fund Society's Regeneron Pharmaceuticals position peaked at $1.9M in Q3 2024.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.